An article from October 2, 2024 Applications for “replicon vaccine” approval are currently being submitted in Europe, the United States, and Vietnam. We, the people of all countries, will not accept that. https://bio.nikkeibp.co.jp/atcl/report/16/011900001/24/10/01/00568/ #never #allow #reject #it #日経バイオテク #2024年10月2日 #nikkeibiotechnology #信じらんない ><